A PHP Error was encountered
Severity: Warning
Message: Trying to access array offset on value of type null
Filename: views/press_details.php
Line Number: 14
Backtrace:
File: /home/reportsweb/public_html/application/views/press_details.php
Line: 14
Function: _error_handler
File: /home/reportsweb/public_html/application/controllers/Press_controller.php
Line: 112
Function: view
File: /home/reportsweb/public_html/index.php
Line: 316
Function: require_once
Diagnostics Segment to Drive Growth of Global Nucleic Acid Amplification, Detection, and Diagnostics Market, by Process
According to a new market research study of “Nucleic Acid Amplification, Detection, and Diagnostics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Nucleic Acid, Process, Product Type, Technology, Application, End User, and Geography”, the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019. The market is estimated to grow at a CAGR of 13.4% from 2020 to 2027. The report highlights trends prevailing in the global nucleic acid amplification, detection, and diagnostics market and the factors driving market along with those that act as hindrances.
Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning. Extensively increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems.
Based on process, the global nucleic acid amplification, detection, and diagnosis market is segmented into diagnostics, amplification, and detection. The Diagnostics segment held the largest share of the market in 2019, whereas the same segment is anticipated to register the highest CAGR in the market during the forecast period. The segment is expected to witness substantial growth due to increasing adoption of nucleic acid based diagnostic technologies for disease diagnosis. Moreover, the introduction of new diagnostic instruments are also projected to offer lucrative opportunity for the market growth.
The emergence of coronavirus is expected to have positive impact on the market growth. As nucleic acid related diagnostic technologies offer superior outcomes, majority of the market players are focusing on the product development equipped with nucleic acid tests. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which deterred the market growth by certain extent.
BD, bioMerieux SA, BIO-RAD LABORATORIES INC., THERMO FISHER SCIENTIFIC INC., Illumina, Inc., Danaher, QIAGEN, Abbott, Meridian Bioscience, Inc., and F. HOFFMANN-LA ROCHE LTD. are among the leading companies operating in the nucleic acid amplification, detection, and diagnostics market.
The report segments Global Nucleic Acid Amplification, Detection, and Diagnostics Market as follows:
By Nucleic Acid
- Deoxyribonucleic Acid (DNA)
- Ribonucleic Acid (RNA)
By Process
- Diagnostics
- Amplification
- Transcription-Mediated Amplification (TMA)
- Loop-Mediated Isothermal Amplification (LMIA)
- Strand Displacement Amplification (SDA)
- Helicase-Dependent Amplification (HDA)
- Nucleic Acid Sequence-Based Amplification (NASBA)
- Others
- Detection
By Product Type
- Kits and Reagents
- Assays
- Systems
By Technology
- Polymerase Chain Reaction (PCR)
- Quantitative PCR (qPCR)
- Reverse-Transcriptase (RT–PCR)
- Multiplex PCR
- Nested PCR
- In-situ PCR
- Others
- Next Generation Sequencing (NGS)
- Isothermal Amplification Technology
- Target Amplification Systems
- Probe Amplification Systems
- Signal Amplification Systems
- Direct Nucleic Acid Detection
- Aptamers
- DNA Biosensors
- Others
- CRISPR-Cas9
By Application
- Infectious Diseases
- Genetic Diseases
- Oncology
- Forensic Testing
- Paternity Testing
- Others
By End User
- Hospital and Clinics
- Diagnostic Centers
- Research Institutes
- Others
By Geography
- North America
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- South & Central America (SCAM)
- Brazil
- Argentina
- Rest of South & Central America
